ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 89,100
-4,500 (-4.81%)
Aug 11, 2026, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 5.24 trillion as of August 11, 2026. Its market cap has increased by 28.89% in one year.
Market Cap
5.24T
Enterprise Value
5.11T
Revenue
90.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
89,100.00
ChartMarket Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 5.24T, an increase of 761.04%. That is a compound annual growth rate of 32.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 5.24T | -52.47% |
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 10.22T |
| SK Biopharmaceuticals | 6.69T |
| HLB Co., Ltd. | 4.96T |
| Peptron | 4.24T |
| LigaChem Biosciences | 4.17T |
| Hugel | 2.95T |
| SK bioscience | 2.89T |
| Voronoi | 2.66T |